Compare · CBLL vs VAR
CBLL vs VAR
Side-by-side comparison of CeriBell Inc. (CBLL) and Varian Medical Systems, Inc. (VAR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBLL and VAR operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CBLL carries a market cap of $1.02B.
- CBLL has hit the wire 10 times in the past 4 weeks while VAR has been quiet.
- CBLL has more recent analyst coverage (8 ratings vs 0 for VAR).
- Company
- CeriBell Inc.
- Varian Medical Systems, Inc.
- Price
- -
- -
- Market cap
- $1.02B
- -
- 1M return
- -5.42%
- -
- 1Y return
- +102.71%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- n/a
- News (4w)
- 10
- 0
- Recent ratings
- 8
- 0
Latest CBLL
- Director Burke William W exercised 18,000 shares at a strike of $4.70 and sold $479,480 worth of shares (18,000 units at $26.64) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by CeriBell Inc.
- Director Taylor Joseph Michael sold $277,644 worth of shares (10,200 units at $27.22), decreasing direct ownership by 21% to 38,278 units (SEC Form 4)
- Chief Technology Officer Woo Raymond exercised 4,887 shares at a strike of $3.65 and sold $131,754 worth of shares (4,887 units at $26.96) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by CeriBell Inc.
- CeriBell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ceribell Reports Third Quarter 2026 Financial Results
- Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Latest VAR
- Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian
- Varian and Icon Group Partner to Extend Commitment to Global Cancer Care
- SEC Form 15-12B filed by Varian Medical Systems, Inc.
- SEC Form 4: Balser Jeffrey R. returned 2,824 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: BUTEL JEAN LUC returned 4,048 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: DUGAN REGINA E returned 12,396 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: ECKERT R ANDREW gifted 447 units of Common Stock and returned 13,826 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: BRUNER JUDY returned 6,779 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: ILLINGWORTH DAVID J returned 15,369 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: WILSON DOW R returned 39,231 units of Common Stock to the company and gifted 65,558 units of Common Stock, decreasing direct ownership by 100% to 0 units